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Essential gene
Uncharacterized geneA thermosensitive strain (YMR134Wts) of the essential gene YMR134W presented up to 40% less
ergosterol, threefold lower oxygen consumption and impaired growth on respiratory conditions.
The iron content in the mitochondrial fraction of YMR134Wts cells was considerably low, despite
these cells uptake and accumulate more iron from the culture media than wild-type cells.
YMR134Wts cells were also more susceptible to oxidative stress. The results suggest that Ymr134wp
is essential to aerobic growth due to its function in ergosterol biosynthesis, playing a role in main-
taining mitochondrial and plasma membrane integrity and consequently impacting the iron
homeostasis, respiratory metabolism and antioxidant response.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In 1997, applying a random mutagenesis approach, Babcock
et al. isolated a mutant that was named bm-8, which was unable
to grow under low-iron-containing media. The expression of two
genes, YFH1 or YMR134W, in the bm-8 background resulted in the
complementation of the mutant phenotype back to the wild-type
state. The group described that the gene responsible for allelic
complementation of the low iron growth defect was YMR134W;
however, they focused their studies on the YFH1 gene (able to re-
store the wild-type state of bm-8 only when over-expressed) be-
cause of its homology to the human frataxin gene [1]. Later on,
several studies conﬁrmed the hypothesis that yeast frataxin
(Yfh1p) is a mitochondrial protein involved in iron homeostasis
and it is now accepted as one of the components of the mitochon-
drial machinery involved in [Fe–S] cluster synthesis, acting either
as an iron donor or as a chaperone interacting with desulfurase/scaffold proteins involved in cluster [Fe–S] assembly [2]. In con-
trast, the other gene, YMR134W, was not further studied, but the
bm-8 mutant phenotype suggested that YMR134W may also be in-
volved in iron metabolism.
Previously, genome-wide analyses produced more data about
YMR134W: Ymr134wp is localized at the endoplasmic reticulum
(ER) [3] and it is involved in mitochondria morphogenesis [4]. Later
on, Snoek and Steensma showed that the gene YMR134W is essen-
tial when yeast is grown under aerobic conditions, but not in
anaerobic ones [5]. Finally, Jerry Kaplan (2007), in a communica-
tion posted at the Saccharomyces Genome Database, renamed the
gene YMR134W as ERG29, explaining that ‘‘Erg29p (YMR134W
product) binds to Erg25p and affects its activity; erg29 null mutant
is non-viable in a respiratory competent background but is viable
in a respiratory-defective background; erg29 mutation is syntheti-
cally lethal with mmt1 and mmt2 null mutations.’’ [http://www.
yeastgenome.org/cgi-bin/locusHistory.pl?dbid=S000004741]. Erg25p
is a C-4 sterol methyl oxidase, responsible for catalyzing the
conversion of 4,4-dimethylzymosterol to zymosterol, a precursor
of ergosterol [6]. MMT1 and MMT2 are mitochondrial metal trans-
porters [7], which further indicate the involvement of YMR134W in
mitochondrial and iron metabolism. In the following year, Tarassov
et al. in a genomic-wide study using a Protein-fragment
Fig. 1. Ymr134wp is involved in ergosterol biosynthesis. Total ergosterol was
extracted and quantiﬁed using the Sterol Quantitation Method (SQM) exactly as
described by Arthington-Skaggs et al. (1999). ⁄Expressed as a percentage of the wet
weight of the cell (grown on YPD media). The graph represents the average and
standard deviation (±S.D.) from three independent experiments. The difference
between mutant and wild-type was statistically signiﬁcant for p-value < 0.01
(determined from paired t test) at both temperatures.
Fig. 2. YMR134Wts cells have impaired growth on a respiratory carbon source
(glycerol). SD-URA plates with indicated carbon source. The ﬁrst spot on the left in
each lane corresponds to 5 ll of the cell suspension at A600 nm = 0.2. Four serial 1:5
dilutions were performed from left to right. Figure representative of at least three
independent experiments.
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tween Erg25p and Ymr134wp [8], reinforcing the suggestion that
the last protein could be involved in ergosterol synthesis.
Ergosterol is a major lipid component in yeast membranes that
is associated with structural features such as ﬂuidity and perme-
ability, which are relevant for proper functioning of membrane
proteins. Several steps in the ergosterol biosynthetic pathway are
essential to yeast cell viability, and because of this, the major class
of antifungal—the azoles—target their components [9]. Ergosterol
and iron have a strict relationship because several key enzymes
in ergosterol biosynthesis are iron-centered proteins. In particular,
Erg25p is an oxo-diiron enzyme, essential to aerobic growth of
yeast [6]. In addition, ergosterol synthesis is strictly dependent
on aerobic growth conditions because twelve oxygen molecules
are required for this process [10].
Seventeen years after the completion of the yeast genome se-
quence [11], more than 1600 genes do not have a function clearly
assigned. One of them is YMR134W which is annotated as unchar-
acterized. In the present study, we took advantage of a thermosen-
sitive strain (YMR134Wts) to study the role of YMR134W, an
essential gene in yeast. Here we show that Ymr134wp is involved
in ergosterol biosynthesis and its decreased activity in a thermo-
sensitive strain leads to the formation of functionally impaired
mitochondria affecting the growth of yeast in a respiratory carbonsource (such as glycerol) and the oxygen consumption by the cells.
The mutation also increased the iron uptake of the cells from the
culture media, but it diminished the concentration of iron inside
the mitochondria. Besides, YMR134Wts cells were more sensitive
to oxidative stress and presented increased catalase activity. To-
gether, our data suggest that the phenotypes relating YMR134W
to iron metabolism and mitochondria morphology and function
are due to its role in ergosterol biosynthesis.
2. Materials and methods
2.1. Materials
2.1.1. Thermosensitive strain YMR134Wts genotype
(MATa, ura3D0, leu2D0, his3D1, lys2D0, met15D0, can1D::LEU2,
MFA1pr::His3, ymr134w-ts::URA3). The thermosensitive collection
was kindly provided by Shay Ben-Aroya and Philip Hieter from
the University of British Columbia, Canada [12]. The wild-type
strain BY4741 (MATa, ura3D0, leu2D0, his3D1, met15D0) was pur-
chased from Invitrogen (Invitrogen, Carlsbad, CA, USA) and it was
transformed with empty vector pYES.2.1 TOPO-TA (Invitrogen) to
confer to the wild-type strain the capacity to grow on media with-
out uracil, such as YMR134Wts cells.
2.1.2. Culture media
YPD (yeast extract 1%, peptone 2% and dextrose 2%), YEPG
(yeast extract 1%, ethanol 2%, peptone 2% and glycerol 2%), YPGAL
(yeast extract 1%, peptone 2% and galactose 2%) or SD-URA (Yeast
Nitrogen Base without amino acids 0.7% + ammonium sulfate 0.5%,
glucose 2% or glycerol 2%, DROPOUT 0.12% (mix of all amino acids,
except leucine, uracil, tryptophan, and histidine), histidine 0.8%,
leucine 0.8%, tryptophan 0.8%. Agar (2%) was added to solid media.
Hydrogen peroxide was obtained from Merck (Darmstadt, Ger-
many); tert-butyl hydroperoxide and most of other reagents were
purchased from Sigma–Aldrich (St. Louis, MO, USA).
2.1.3. Viability assay conditions
YMR134Wts and wild-type cells growth analyses on different
carbon sources or exposed to oxidative agents. Cells were initially
inoculated in a 5 ml SD-glucose URA at 25 C, overnight, at
180 rpm (Innova 42R NEW BRUNSWICK SCIENTIFIC, Eppendorf,
Hamburg, Germany). Then cells were diluted on 50 ml fresh media
(YPD, YEPG or SD-glucose URA, speciﬁcally indicated in the ﬁgure
legends) at an optical density (OD600 nm) equal to 0.2 and then
incubated in the permissive temperature (25 C) for 4 h. The cells
were then divided into two equal aliquots and incubated further
at 25 C or at non-permissive temperature (37 C) overnight (pre-
cisely 16 h). The OD600 nm was corrected to 0.2 in sterile water
and an additional four serial dilutions of ﬁvefold were carried
out. An aliquot of 5 ll of each cell dilution was dropped into solid
SD-URAmedia (glucose 2% or glycerol 2% + glucose 0.1% as carbon
source) containing or not (control) hydrogen peroxide (H2O2
0.5 mM) or tert-butyl hydroperoxide (0.75 mM). The plates were
incubated at permissive temperature for 3 days and photographed
(Major Science-UVDI-312; Saratoga, CA, USA).
2.1.4. Quantitation of ergosterol
The amount of ergosterol in the cells was spectrophotometri-
cally determined, exactly as described by Arthington-Skaggs et al.
The method takes advantage of the unique spectral absorption pat-
tern produced by sterols in the range 240–300 nm [13].
2.1.5. Cellular iron uptake measurement
Cells were grown as described above in YPD media. The total
iron of the media was obtained from YPD before cell inoculation.
The iron content was measured colorimetrically using a TPTZ re-
Fig. 3. Impaired oxygen consumption in YMR134Wts cells. Cells were grown on
YEPG media for 16 h harvested by centrifugation, resuspended in buffer containing
sucrose/ethanol as respiratory substrates, and the oxygen uptake was measured
using Clark electrodes for at least 30 min. The graph represents the average and
standard deviation (±S.D.) from three independent experiments. The difference
between mutant and wild-type was statistically signiﬁcant for p-value <0.01
(determined from paired t test) at non-permissive temperature.
Fig. 4. YMR134Wts cells possess low iron concentration in their mitochondria at
non-permissive temperature. Cells were grown on YPGAL to avoid glucose
repression in mitochondria proliferation. The graph represents the average and
standard deviation (±S.D.) from three independent experiments. The difference
between mutant and wild-type was statistically signiﬁcant for p-value <0.01
(determined from paired t test) only at non-permissive temperature.
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duced iron and this complex possesses an extinction coefﬁcient
of 21.600 M1 cm1 at 593 nm (Hach, Loveland, CO, USA). Detec-
tion limits are from 0.01 to 1.80 mg/L. The components of the kit
include ascorbic acid in high concentration to reduce iron content,
so the values represent total iron (reduced and oxidized). After
growth, cells were harvested and supernatant (culture media)
was used to measure the remaining iron content. A standard curve
with known concentrations of FeCl3 was used to calculate iron con-
centrations of the samples.
2.1.6. Cellular iron content measurement
Cells were grown as described above in YPD media and col-
lected by centrifugation after 16 h at permissive or non-permissive
temperature. The cell pellets were washed twice in distillated coldwater and were disrupted in 1 volume of glass beads and 2 vol-
umes of 3.5% sulfosalicylic acid. The suspension was vortexed for
20 min at 4 C in a multifold vortex and harvested at 16,000 g. This
procedure was repeated twice and the supernatants were com-
bined. The pH of the samples was adjusted to pH 4.0 with NaOH,
because TPTZ reagent only produces color between pH 3.0–5.0. Ali-
quots of 50 ll were used to react with TPTZ, as described above.
The pellets of disrupted cells were homogenized with Tris–HCl
pH 7.5 buffered guanidine 5 M overnight and an aliquot of each
sample was used to measure total protein content. Protein concen-
tration was determined with the Bradford reagent from BIORAD
(Hercules, CA, USA), using bovine serum albumin (Sigma) as a
standard.
2.1.7. Mitochondrial iron content
The mitochondrially enriched fraction was obtained from cells
grown on YPGAL, and following the protocol exactly as described
earlier [14]. The mitochondria were then lysed in sterile water
and an aliquot possessing 200 lg of protein (previously deter-
mined with Bradford reagent) of this homogenate was used to
measure the iron content as described above.
2.1.8. Oxygen uptake measurements
Experiments were carried out using a Clarke-type electrode in a
glass cuvette equipped with magnetic stirring. To adjust the uptake
for cell concentration, the cell dry weight was measured until three
consecutive constant values. The cells were incubated at 30 C in
buffer containing HEPES 10 mM pH 7.2, sucrose 250 mM, KCl
65 mM and ethanol 2.5 mM for at least 30 min [14].
2.1.9. Catalase activity assay
Oxygen-release measurements were carried out using a Clarke-
type electrode in a glass cuvette equipped with magnetic stirring.
To measure oxygen release, corresponding to catalase activity,
the cells (grown on YPD) were disrupted in a vortex using glass
beads in phosphate buffer saline 1 with 1 mM of PMSF added
to inhibit proteolysis. The protein extract was harvested at
16,000g for 30 min at 4 C, the supernatant was collected and the
total protein amount was quantiﬁed by Bradford assay [15]. Oxy-
gen release due to catalase activity (2H2O2? 2H2O + O2) in cell ex-
tracts was speciﬁcally determined using a Clark electrode at 30 C
(Yellow Springs Instrument Co.). The saturating oxygen concentra-
tion, which corresponds to the full scale of the electrode, was taken
to be 0.225 mM [15]. The initial peroxide concentration added was
1 mM in 50 mM HEPES and 100 mM NaCl. The activity observed
was completely abolished when 1 mM azide (inhibitor of catalase)
was added previously to peroxide in the reaction media.3. Results and discussion
The data published about phenotypes (aberrant mitochondrial
morphology [4] and inability to growth in iron deﬁcient media
[1]) and about protein physical interactions (with Erg25p [8], a
key enzyme in ergosterol biosynthesis) lead us to hypothesize that
Ymr134wp is involved in ergosterol biosynthesis in yeast. To test
this hypothesis, the content of total ergosterol was measured in
wild-type and YMR134Wts cells (Fig. 1). YMR134Wts cells showed
almost 40% less ergosterol compared with the wild-type strain at
non-permissive temperature, suggesting a signiﬁcant importance
of Ymr134wp to the synthesis of this lipid. Corroborating this idea,
Ymr134wp is localized in the ER [3], where most of the compo-
nents of the superpathway of ergosterol biosynthesis are present.
In addition, ergosterol mutant strains and ymr134w mutant cells
share several common phenotypes. Mutation of erg25 (LT06) [6],
erg3 and erg6 [16] renders cells unable to grow under low iron
Fig. 5. Consumption and accumulation of iron is increased in YMR134Wts cells. (A) The residual iron content on YPD media was measured at 0, 8 and 16 h after cell
inoculation. The total initial iron content on YPD media was 1.8 mg/L. (B) Total cellular iron content was measured at 16 h after cell inoculation as described in ‘‘Section 2’’.
The graphs represent the average and standard deviation (±S.D.) from three independent experiments. The difference between mutant and wild-type was statistically
signiﬁcant for p-value <0.01 (determined from paired t test) at both temperatures in (A) and only at permissive temperature in (B).
Fig. 6. YMR134Wts cells are sensitive to oxidative stress. SD-URA plates in the absence (control) or presence of the oxidant agents, hydrogen peroxide (H2O2), and tert-butyl
hydroperoxide (t-BOOH). Serial dilution performed as described in the legend of Fig. 2. Figure representative of at least three independent experiments.
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[1]. Strains whose expression of YMR134W or ergosterol biosyn-
thetic genes was strongly inhibited by doxycycline addition
(through the regulation of a TetO7 promoter) produced aberrant
mitochondrial morphology proﬁle [4]. In this regard, the ergosterol
deﬁciency observed in YMR134Wts cells (Fig. 1) is in agreement
with these previous results and it can explain them, implicating
Ymr134wp as a key component of ergosterol biosynthesis.
Ymr134wp was ﬁrstly related to iron metabolism [1] and sev-
eral studies have suggested the relationship between mitochon-
drial function (mainly oxygen consumption) and iron metabolism
[17–21]. It is well accepted that heme (an iron cofactor synthesized
into mitochondria) is the oxygen sensor molecule in yeast and that
this pathway is mediated by the Heme Activator Protein (Hap1p)
[22]. In particular, Hap1p induces the expression of ROX1 repressor
that, in turn, inhibits the expression of the ergosterol import sys-
tem from extracellular media in the presence of oxygen [23]. So,
ergosterol supplementation under aerobic conditions is not effec-
tive in reverting phenotype of mutant genes involved in ergosterolbiosynthesis because the absence of its importer system. However,
the supplementation of media with ergosterol under anaerobic
conditions renders reversal of lethal phenotype of Dymr134w [5]
what reinforce our data involving this gene in ergosterol biosyn-
thesis. Besides, the ergosterol biosynthesis links iron and oxygen
cell-requirements because this anabolic pathway requires several
iron-dependent enzymes (heme and oxo-diiron) and twelve oxy-
gen molecules as substrate to generate ergosterol [10]. Remark-
ably, it has been suggested that the ability of organisms, such as
S. cerevisiae, to grow aerobically or anaerobically is due to the pres-
ence of sterol importers that are only active in the absence of oxy-
gen [5].
Since depletion of any gene involved in ergosterol biosynthetic
pathway leads to mitochondrial morphology aberration [4], it
would be expected that YMR134Wts cells possessed impaired mito-
chondrial function and deﬁcient growth in a respiratory carbon
source, such as glycerol. In fact, YMR134Wts cells grew poorly in
the presence of this carbon source (Fig. 2). In addition, oxygen con-
sumption was also analyzed to assess mitochondrial function and a
Fig. 7. YMR134Wts cells are in oxidative stress. Cells were grown on YPD. Catalase
activity measured by the release of molecular oxygen, one of the reaction products.
The graph represents the average and standard deviation (±S.D.) from three
independent experiments. The difference between mutant and wild-type was
statistically signiﬁcant for p-value <0.01 (determined from paired t test) at both
temperatures.
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permissive temperature in YMR134Wts cells (Fig. 3), suggesting
that the mitochondrial function was affected.
Due to the ability of YFH1 gene overexpression to rescue bm-8
phenotype to wild-type state, it was expected that YMR134Wts cells
would present similar phenotype in respect to the mitochondrial
iron homeostasis. yfh1 mutant cells accumulate high amounts of
iron into mitochondria compartment, but this metal is not avail-
able to biological processes, such as [Fe–S] cluster biogenesis, be-
cause it is precipitated with phosphate [21]. Unexpectedly,
YMR134Wts cells at the non-permissive temperature possessed al-
most half of the concentration of iron in the mitochondria
(Fig. 4). Therefore, in this aspect, inhibition of the function of the
YMR134W and the YFH1 genes resulted in opposite outcomes
(depletion or accumulation of mitochondrial iron content, respec-
tively). Although the overexpression of Yfh1p was able to comple-
ment bm-8 growth defects, this protein has no relation to
ergosterol biosynthesis, since the levels of ergosterol in yfh1 mu-
tants are normal [24]. In contrast to Yfh1p, Ymr134wp is not local-
ized in mitochondria but in the ER [3], features which taken
together could be related to these distinct phenotypes.
Next, the ability of YMR134Wts cells to uptake iron from the cul-
ture medium and accumulate this metal inside the cell was inves-
tigated. Remarkably, YMR134Wts cells consumed high amounts of
iron from the culture media and accumulate it (Fig. 5). After 16 h
of growth at permissive or non-permissive temperatures,
YMR134Wts cells almost completely exhausted the iron content of
the media (Fig. 5A). Interesting, in wild-type strain the non-per-
missive temperature increased the iron accumulation in the cells
(Fig. 5B). At least to our knowledge, this phenomenon has not yet
been reported to yeast, and deserves further studies. In any case,
the data described in Fig. 5 suggests that YMR134Wts cell iron up-
take is deregulated and cells probably accumulate excessive iron
in the cytosol due to the fact that delivery of iron to mitochondria
in these cells is impaired (Fig. 4), suggesting a possible condition of
oxidative stress [20,25].
Therefore, the response of YMR134Wts cells to oxidative stress
was investigated. Accordingly, YMR134Wts cells presented highsensitivity not only to hydrogen but also to tert-butyl hydroperox-
ide insult (Fig. 6). In fact, at both temperatures (25 or 37 C),
YMR134Wts cells suffered a signiﬁcant decrease in their viability
in the presence of peroxide. In addition, the catalase activity was
measured in both strains, since this enzyme participates in the
antioxidant response. YMR134Wts cells displayed double the cata-
lase activity at the non-permissive temperature when compared
with wild-type (Fig. 7). However, these cells presented lower cata-
lase activity at permissive temperature, which is in agreement
with cell sensitivity to oxidant insult in this growth condition. It
is noteworthy to observe that, also at the permissive temperature,
YMR134Wts cells consumed and accumulated excessive iron,
explaining this sensitivity to hydroperoxides (Fig. 5).
In agreement with these results, Folmer et al. [26] showed that
during adaptation to hydrogen peroxide the plasma membrane
suffers modulation of their biophysical properties, resulting in de-
creased diffusion rate of hydrogen peroxide. Interestingly, this
modulation was dependent on ergosterol biosynthesis, since Derg3
or Derg6 cells, displays increased permeability to hydrogen perox-
ide [26]. So, it is expected that in addition to excess of iron,
YMR134Wts cells are also more permeable to peroxides, both fac-
tors probably contributing to lower viability of this strain when ex-
posed to these oxidants (Fig. 6). In addition, there is a relationship
between the progression in the pathway from ergosterol precur-
sors toward ergosterol and the ability of the lipid to protect mem-
brane against oxidation, inﬂuencing the cell resistance to oxidative
stress [27]. Considering that Ymr134wp is important to Erg25p
function, the ergosterol pathway was disrupted early in
YMR134Wts cells, leading to formation of a less protective struc-
tural lipid against oxidative stress.
The data suggest that Ymr134wp is a key component in ergos-
terol biosynthesis, leading the mitochondria of YMR134Wts cells to
present problems in their membrane composition, probably result-
ing in deﬁciency of iron transport from the cytosol to the mito-
chondria. The critical transporters involved in mitochondrial iron
import are still poorly understood. Among the probable proteins
involved in this process are Mmt1p, Mmt2p and Mrs3p, Mrs4p.
Mmt1p and Mmt2p (mitochondrial metal transporters) are puta-
tive mitochondrial iron transporters since their over-expression in-
creases iron accumulation into mitochondria by 2- to 5-fold when
compared to the wild-type [7]. Bioinformatics’ predictions suggest
that both Mmt1p and Mmt2p are integral to the membrane
(TMHMM tool, an application available at The Center for Biological
Sequence Analysis at the Technical University of Denmark DTU).
However, the role of these transporters is controversial since the
double mutantDmmt1Dmmt2 does not show decreased mitochon-
drial iron content [28]. The best candidates for mitochondrial iron
importers are Mrs3 and Mrs4 proteins (‘‘Mitochondrial RNA Splic-
ing’’) whose double deletion causes impairment in mitochondrial
iron accumulation [28,29]. It is expected that mutations damaging
ergosterol biosynthesis result in membrane ﬂuidity alterations,
impairing the proper function of integral membrane protein trans-
porters. Consequently, mutations in iron transporters to the mito-
chondria in ymr134w mutant cells could cause a severe iron
deﬁciency in the organelles of these cells, leading to lethality. This
hypothesis is in agreement with the observation of Jerry Kaplan
(2007) that ‘‘erg29 mutation is synthetically lethal with mmt1
and mmt2 null mutations’’. The lower intra-mitochondrial iron
concentration in YMR134Wts cells (Fig. 5) could be related to the
inappropriate function of mitochondrial iron transport process.
The relationship of the ergosterol content and the mitochondria
proﬁle is known for a long time (Jollow et al.). When cells are cul-
tivated in anaerobic conditions and limiting the levels of the lipids
(ergosterol, and unsaturated fatty acids) mitochondrial and vacu-
ole morphology are profoundly altered [30]. In agreement with this
data, the results presented here show that low ergosterol content
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composition, resulting in low iron concentration inside the orga-
nelle, low oxygen consumption, and consequently less ability to
grow in a respiratory carbon source. In consequence, the disturbed
iron homeostasis and altered plasma membrane peroxide perme-
ability prone cells to oxidative stress.
4. Conclusions
In conjunction, the data suggests the involvement of the
YMR134W gene in the ergosterol biosynthesis, which affects mito-
chondrial and plasma membrane composition, and, in turn, has
implications for iron homeostasis, mitochondria function, respira-
tory growth and antioxidant cell protection.
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